A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1

Preserving Clinical Trial Integrity During the Coronavirus Pandemic

(2020) Mary M. McDermott et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Conducting Clinical Research During the COVID-19 Pandemic

(2020) Thomas R. Fleming et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis

(2020) Spyridon Siafis et al.   Molecular Autism

Excitation-inhibition balance as a framework for investigating mechanisms in neuropsychiatric disorders

(2019) Vikaas S. Sohal et al.   MOLECULAR PSYCHIATRY

A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder

(2019) Federico Bolognani et al.   Science Translational Medicine

GABAergic inhibition gates perceptual awareness during binocular rivalry

(2019) Jeff Mentch et al.   JOURNAL OF NEUROSCIENCE

Decomposing alpha and 1/f brain activities reveals their differential associations with cognitive processing speed

(2019) Guang Ouyang et al.   NEUROIMAGE

Sensory processing in autism spectrum disorders and Fragile X syndrome—From the clinic to animal models

(2017) D. Sinclair et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Validation of the Epworth Sleepiness Scale for Children and Adolescents using Rasch analysis

(2017) Kitty C. Janssen et al.   SLEEP MEDICINE

Shifting brain inhibitory balance and connectivity of the prefrontal cortex of adults with autism spectrum disorder

(2017) L A Ajram et al.   Translational Psychiatry

Measuring neural excitation and inhibition in autism: Different approaches, different findings and different interpretations

(2016) Abigail Dickinson et al.   BRAIN RESEARCH

Advancing the understanding of autism disease mechanisms through genetics

(2016) Luis de la Torre-Ubieta et al.   NATURE MEDICINE

Developmental timing and critical windows for the treatment of psychiatric disorders

(2016) Oscar Marín   NATURE MEDICINE

Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial

(2016) Jeremy Veenstra-VanderWeele et al.   NEUROPSYCHOPHARMACOLOGY

Costs of Autism Spectrum Disorders in the United Kingdom and the United States

(2014) Ariane V. S. Buescher et al.   JAMA Pediatrics

The neurobiology of autism spectrum disorders

(2013) M. Parellada et al.   EUROPEAN PSYCHIATRY

Global Prevalence of Autism and Other Pervasive Developmental Disorders

(2012) Mayada Elsabbagh et al.   Autism Research

What is the Source of the EEG?

(2012) Timo Kirschstein et al.   CLINICAL EEG AND NEUROSCIENCE

The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults

(2011) Kelly Posner et al.   AMERICAN JOURNAL OF PSYCHIATRY

Defective GABAergic Neurotransmission and Pharmacological Rescue of Neuronal Hyperexcitability in the Amygdala in a Mouse Model of Fragile X Syndrome

(2010) J. L. Olmos-Serrano et al.   JOURNAL OF NEUROSCIENCE

Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes

(2010) Hsiao-Tuan Chao et al.   NATURE

Increased GABAB Receptor-Mediated Signaling Reduces the Susceptibility of Fragile X Knockout Mice to Audiogenic Seizures

(2009) L. K. K. Pacey et al.   MOLECULAR PHARMACOLOGY